Valuation Nile Pharmaceuticals and Chemical Industries Company

Stocks

End-of-day quote Egyptian Exchange 29/10/2026			5-day change	1st Jan Change
283.00 ^EGP	+11.20%		+6.19%	+182.38%

30/09	EI- Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2026	CI
22/05	EI- Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Market Cap ¹	354.1	359	404.9	699.2	1,465	8,202
Change	-	1.4%	12.77%	72.69%	109.54%	459.75%
Enterprise Value (EV) ¹	287.9	385.2	596	1,240	2,433	9,739
Change	-	33.83%	54.7%	108.1%	96.15%	300.34%
P/E	5.5x	4x	3.4x	7.75x	11.7x	32x
PBR	0.95x	0.83x	0.85x	1.49x	1.97x	7.66x
PEG	-	0.1x	0.1x	-0.3x	-0.2x	1.4x
Capitalization / Revenue	0.47x	0.41x	0.4x	0.61x	1.14x	3.84x
EV / Revenue	0.38x	0.44x	0.59x	1.09x	1.89x	4.56x
EV / EBITDA	2.67x	2.76x	3.39x	7.97x	7.9x	16.2x
EV / EBIT	3.01x	3.07x	3.66x	8.64x	8.71x	18.2x
EV / FCF	5.53x	-6.04x	-4.67x	-5.34x	-4.75x	-15.3x
FCF Yield	18.1%	-16.6%	-21.4%	-18.7%	-21.1%	-6.52%
Dividend per Share ²	2	2.97	5	3.71	2	-
Rate of return	5.72%	8.38%	12.5%	5.37%	4.1%	-
EPS ²	6.363	8.856	11.77	8.911	4.191	5.127
Distribution rate	31.4%	33.5%	42.5%	41.6%	47.7%	-
Net sales ¹	755.5	876.8	1,005	1,143	1,290	2,134
EBITDA ¹	107.7	139.4	175.9	155.5	307.9	602
EBIT ¹	95.6	125.4	162.8	143.5	279.3	535.2
Net income ¹	64.42	89.67	119.2	90.23	125.7	256.4
Net Debt ¹	-66.22	26.21	191.1	540.9	967.4	1,537
Reference price ²	34.97	35.46	39.99	69.06	48.84	164.03
Nbr of stocks (in thousands)	10,125	10,125	10,125	10,125	30,000	50,000
Announcement Date	14/9/21	19/9/22	20/9/23	24/9/24	9/9/25	30/9/26

¹EGP in Million²EGP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NILE PHARMACEUTICALS AND CHEMICAL INDUSTRIES COMPANY	-	-	-	-	253M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.71B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%